1. Home
  2. SHC vs GRFS Comparison

SHC vs GRFS Comparison

Compare SHC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

N/A

Current Price

$19.35

Market Cap

5.0B

Sector

Health Care

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$8.00

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHC
GRFS
Founded
2015
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.2B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
SHC
GRFS
Price
$19.35
$8.00
Analyst Decision
Buy
Hold
Analyst Count
7
2
Target Price
$20.33
$10.15
AVG Volume (30 Days)
3.1M
529.1K
Earning Date
05-05-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
68.75
N/A
EPS
0.28
N/A
Revenue
$1,163,617,000.00
N/A
Revenue This Year
$7.51
$4.49
Revenue Next Year
$6.00
$6.42
P/E Ratio
$68.64
$18.67
Revenue Growth
5.74
N/A
52 Week Low
$13.09
$6.96
52 Week High
$19.85
$10.23

Technical Indicators

Market Signals
Indicator
SHC
GRFS
Relative Strength Index (RSI) 65.71 54.88
Support Level $15.07 $7.87
Resistance Level $19.82 $8.36
Average True Range (ATR) 0.49 0.19
MACD 0.02 -0.01
Stochastic Oscillator 76.61 46.43

Price Performance

Historical Comparison
SHC
GRFS

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: